A multicenter, randomized, double-blind, placebo-controlled parallel group 8-week study to evaluate the efficacy and safety of chewable montelukast when initiated at the start of the school year in pediatric patients with chronic asthma

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled parallel group 8-week study to evaluate the efficacy and safety of chewable montelukast when initiated at the start of the school year in pediatric patients with chronic asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 26 Jan 2009 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 26 Jan 2009 Planned number of patients changed from 1100 to 1162 as reported by ClinicalTrials.gov.
    • 26 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top